Bank of America’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Bank of America’s Portfolio SXTPW Stock Details SXTPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100	Closed	-$4	–	8174
2023 Q4	$4	Hold	100	–	–	﹤0.01%	7869
2023 Q3	$35	Buy	+100	New	+$43	﹤0.01%	7533

Other funds holding SXTPW

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's SXTPW Position: Q1 2024 in Review

Bank of America sold out of 60 Degrees Pharmaceuticals Warrant (SXTPW) in Q1 2024, closing a stake of 100 shares — an estimated $4 sold.

Bank of America first reported a position in SXTPW in Q3 2023 and held it in 2 quarters. The position peaked at $35 in Q3 2023. 8 funds tracked by Wall St. Rank hold SXTPW as of Q1 2024.

Bank of America reported no remaining 60 Degrees Pharmaceuticals Warrant position as of Q1 2024 after selling out during the quarter.
Bank of America sold 100 60 Degrees Pharmaceuticals Warrant shares in Q1 2024, an estimated $4.
Bank of America first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2023 and held it in 2 quarters.
Bank of America's 60 Degrees Pharmaceuticals Warrant position peaked at $35 in Q3 2023.
8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.